Refocus Group IncGrey Market:RFCS
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Refocus Group Inc | 20.0 | 0.0x | --- |
Anthera Pharmaceuticals Inc | 30.0 | 0.0x | --- |
Cantabio Pharmaceuticals Inc | 22.8K | 0.0x | --- |
Pathfinder Cell Therapy Inc | 670.0 | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Miravant Medical Technologies | 40.0 | 0.0x | --- |
Company Information
Refocus Group, Inc. is a medical device company. The Company is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. The Company’s product, VisAbility Micro Insert System, is a binocular presbyopia treatment, which works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.
Contact Information
- Headquarters
- 9155 Sterling Street, Suite 160IRVING, TX, United States 75063
- Phone
- 972-893-1008
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Glen Bradley
- President, Chief Executive Officer, Director
- Douglas Williamson
- Chief Financial Officer, Senior Vice President of Business Development
- Zack Thompson
- Chief Financial Officer, Chief Technology Officer, Secretary
- Mark Cox
- Director
- Kenneth Elmgren
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 24.7M |
Refocus Group Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.20 |
Book Value | $-0.10 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
